GO:0006007 glucose catabolic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006007 glucose catabolic process describes the chemical reactions and pathways that break down glucose, the aldohexose gluco-hexose, into smaller metabolites.
• Glucose catabolism is not a single linear route; it includes glycolysis, the pentose phosphate pathway, and mitochondrial oxidation, and its intermediates signal nutrient status to growth-regulatory machinery such as mTORC1.
• Compartmentalized glucose catabolism supports midgestation mammalian development, and disrupting specific catabolic steps can cause developmental failure.
• Competitive catabolism between glucose and other fuels drives hyperglycemia and hyperinsulinemia in obesity, making catabolic flux a therapeutic target.
• In cancer, catabolic metabolism is rewired during epithelial-mesenchymal transition (EMT), linking glucose breakdown to metastatic potential.
• CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of genes in glucose catabolic process, from single enzymes to whole pathways [1,2,5].
Description
Glucose catabolic process (GO:0006007) is the set of biochemical reactions that convert glucose into smaller molecules, releasing energy and generating metabolic intermediates for biosynthesis. It is a core biological process because glucose is a primary fuel for most cells, and its breakdown products feed into mitochondrial oxidation, amino acid synthesis, and signaling pathways that control cell growth and survival [1,2]. Researchers study this process to understand normal physiology, metabolic disease, and cancer metabolism, where catabolic flux is often reprogrammed [5,6]. The QuickGO definition states that GO:0006007 encompasses the chemical reactions and pathways resulting in the breakdown of glucose, the aldohexose gluco-hexose. This definition intentionally includes multiple routes, such as glycolysis, the pentose phosphate pathway, and entry into the tricarboxylic acid (TCA) cycle, rather than a single enzymatic step [1,2]. Because glucose catabolism intersects with nutrient sensing, redox balance, and biosynthetic precursor supply, it is a frequent subject of genetic and pharmacological studies [1,5]. In this article, we summarize the mechanism, key genes, disease links, and experimental models for GO:0006007, with all claims supported by published literature.
glucose catabolic process At A Glance
| GO ID | GO:0006007 |
|---|---|
| GO term | glucose catabolic process |
| Ontology | biological_process |
| Synonym | glucose breakdown; glucose catabolism; glucose degradation |
| Definition | The chemical reactions and pathways resulting in the breakdown of glucose, the aldohexose gluco-hexose. |
| Major function | Energy production, generation of biosynthetic precursors, and nutrient signaling |
| Key pathways | Glycolysis, pentose phosphate pathway, TCA cycle, oxidative phosphorylation |
| Compartment | Cytosol and mitochondria |
| Related processes | Cellular respiration, gluconeogenesis, glycogen metabolism |
What Is GO:0006007?
In our own words, GO:0006007 glucose catabolic process refers to all enzymatic reactions and pathways that degrade glucose, the six-carbon aldohexose also called gluco-hexose, into smaller carbon compounds. This includes the breakdown of glucose to pyruvate via glycolysis, the oxidative and non-oxidative branches of the pentose phosphate pathway, and the subsequent oxidation of pyruvate-derived acetyl-CoA in the TCA cycle and oxidative phosphorylation. The term is a biological process annotation, meaning it describes a series of molecular events rather than a single molecular function or cellular component. It is distinct from glucose biosynthetic process (gluconeogenesis) and from glucose transport, although transport is required for glucose to enter catabolic pathways. The QuickGO definition emphasizes that the process results in the breakdown of glucose, and it is associated with synonyms such as glucose breakdown, glucose catabolism, and glucose degradation.
Why Is glucose catabolic process Important in Cell Biology?
Glucose catabolic process is central to cellular energy homeostasis and biosynthetic metabolism, and its dysregulation is implicated in major human diseases including obesity, diabetes, cancer, and developmental disorders [2,5,6]. Because catabolic intermediates such as dihydroxyacetone phosphate signal glucose availability to mTORC1, this pathway directly influences cell growth and proliferation. In obesity, competitive catabolism between glucose and other fuels can drive hyperglycemia and hyperinsulinemia, highlighting the pathway as a therapeutic target. During cancer EMT, catabolic metabolism is reprogrammed to support migration and invasion, linking glucose breakdown to metastasis. In development, compartmentalized metabolism is required for midgestation mammalian embryogenesis, and disrupting specific catabolic steps causes developmental failure. Therefore, understanding GO:0006007 is essential for both basic biology and translational research.
• Provides ATP and reducing equivalents (NADH, NADPH) for cellular work and biosynthesis.
• Generates metabolic intermediates that feed into amino acid, nucleotide, and lipid synthesis [1,2].
• Signals nutrient availability to mTORC1 via dihydroxyacetone phosphate, linking catabolism to growth control.
• Supports midgestation mammalian development; compartmentalized catabolism is essential for embryogenesis.
• Contributes to hyperglycemia and hyperinsulinemia in obesity through competitive catabolism.
• Is reprogrammed during cancer EMT, supporting metastatic phenotypes.
• Is a target of metformin and other drugs that modulate endogenous glucose production.
• Influences insulin resistance and metabolic inflexibility, as shown in Ataxia-Telangiectasia models.
• Is conserved from yeast to humans, enabling genetic studies in model organisms.
• Provides a rich set of enzymes and transporters for CRISPR-based functional genomics [1,2,5].
What Happens During glucose catabolic process?
Glycolysis: Conversion of Glucose to Pyruvate
In simple terms: Glycolysis is the first major step where glucose is split into two molecules of pyruvate, producing a small amount of energy.
Glycolysis is a cytosolic pathway of ten enzymatic steps that converts one molecule of glucose into two molecules of pyruvate, with a net gain of two ATP and two NADH. The pathway is initiated by hexokinase or glucokinase, which phosphorylates glucose to glucose-6-phosphate, trapping it in the cell. Subsequent steps include isomerization, phosphorylation, and cleavage into two three-carbon molecules, followed by oxidation and substrate-level phosphorylation. The final step, catalyzed by pyruvate kinase, produces pyruvate. Glycolytic intermediates such as dihydroxyacetone phosphate (DHAP) can signal glucose availability to mTORC1, integrating catabolism with growth control. In yeast, sugar transporters are required for glucose uptake prior to catabolism, and their regulation is critical for metabolic adaptation.
Pentose Phosphate Pathway: NADPH and Ribose-5-Phosphate Production
In simple terms: The pentose phosphate pathway is a side route that makes building blocks for nucleotides and provides reducing power for antioxidant defense.
The pentose phosphate pathway (PPP) branches from glycolysis at glucose-6-phosphate. The oxidative branch, catalyzed by glucose-6-phosphate dehydrogenase (G6PD), produces NADPH and ribulose-5-phosphate. NADPH is essential for reductive biosynthesis and glutathione recycling, while ribose-5-phosphate is a precursor for nucleotide synthesis. The non-oxidative branch interconverts sugar phosphates and can feed back into glycolysis. The PPP is critical for proliferating cells and is often upregulated in cancer. Although not always classified under GO:0006007, the PPP is a glucose catabolic route because it breaks down glucose-6-phosphate. Its activity is coordinated with glycolytic flux to meet cellular demands [1,6].
Mitochondrial Oxidation: TCA Cycle and Oxidative Phosphorylation
In simple terms: Pyruvate from glycolysis enters mitochondria, where it is fully oxidized to carbon dioxide and water, producing most of the cell's ATP.
Pyruvate produced by glycolysis is transported into mitochondria and converted to acetyl-CoA by the pyruvate dehydrogenase complex. Acetyl-CoA enters the TCA cycle, where it is oxidized to CO2, generating NADH and FADH2. These electron carriers donate electrons to the electron transport chain, driving oxidative phosphorylation and ATP synthesis. This mitochondrial phase of glucose catabolism is tightly coupled to oxygen availability and is a major source of reactive oxygen species. Compartmentalized metabolism, including mitochondrial oxidation, is essential for midgestation mammalian development, as shown by genetic studies in mice. In obesity, competitive catabolism between glucose and fatty acids can alter mitochondrial flux and contribute to hyperglycemia.
Regulation by Nutrient-Sensing Pathways
In simple terms: Cells sense how much glucose is available and adjust catabolic rates through signaling pathways like mTORC1.
Glucose catabolism is regulated by nutrient-sensing pathways that match flux to cellular needs. Dihydroxyacetone phosphate, a glycolytic intermediate, signals glucose availability to mTORC1, promoting anabolic growth when glucose is abundant. Conversely, low glucose activates AMPK and inhibits mTORC1, reducing biosynthesis. In obesity, competitive catabolism between glucose and branched-chain amino acids or fatty acids can exacerbate hyperglycemia and hyperinsulinemia. Metformin, a first-line diabetes drug, paradoxically increases endogenous glucose production while modulating catabolic flux, illustrating the complexity of systemic regulation. In Ataxia-Telangiectasia, alpha-ketoglutarate supplementation mitigates insulin resistance and metabolic inflexibility, further linking catabolic intermediates to systemic metabolic health.
Catabolic Reprogramming in Cancer and EMT
In simple terms: Cancer cells often change how they break down glucose to support rapid growth and spread.
Cancer cells frequently reprogram glucose catabolism to support biosynthesis and survival. During epithelial-mesenchymal transition (EMT), catabolic metabolism is rewired, with increased glycolytic flux and altered mitochondrial function. This metabolic shift provides energy and building blocks for migration and invasion. The pentose phosphate pathway is often upregulated to supply NADPH for antioxidant defense and ribose for nucleotide synthesis. Targeting glucose catabolism is therefore a potential therapeutic strategy in cancer. Understanding these adaptations requires functional studies using CRISPR and other genetic tools.
Key Genes Involved in GO:0006007 glucose catabolic process
The following genes encode enzymes, transporters, and regulators that directly participate in or control glucose catabolic process (GO:0006007).
| Gene | Major Role | Research Relevance |
|---|---|---|
| HK2 | Hexokinase 2; phosphorylates glucose to glucose-6-phosphate | Key glycolytic enzyme; target for cancer metabolism studies [1,6] |
| G6PD | Glucose-6-phosphate dehydrogenase; rate-limiting enzyme of pentose phosphate pathway | Produces NADPH; linked to redox balance and cancer [1,6] |
| PKM | Pyruvate kinase; catalyzes final step of glycolysis | Regulates glycolytic flux; isoforms PKM1/PKM2 studied in cancer |
| PDHX | Pyruvate dehydrogenase complex component; converts pyruvate to acetyl-CoA | Links glycolysis to TCA cycle; target for metabolic disease |
| IDH2 | Isocitrate dehydrogenase 2; TCA cycle enzyme | Mutations in cancer; involved in mitochondrial metabolism |
| SDHA | Succinate dehydrogenase complex subunit A; TCA cycle and electron transport | Links TCA cycle to oxidative phosphorylation; cancer and development |
| SLC2A1 | GLUT1 glucose transporter; mediates glucose uptake | Required for glucose catabolism; studied in cancer and development |
| SLC2A4 | GLUT4 glucose transporter; insulin-responsive | Key in glucose homeostasis and diabetes |
| GCK | Glucokinase; phosphorylates glucose in liver and pancreas | Regulates glucose sensing and catabolism |
| PFKM | Phosphofructokinase; rate-limiting enzyme of glycolysis | Controls glycolytic flux; mutations cause glycogen storage disease |
| GAPDH | Glyceraldehyde-3-phosphate dehydrogenase; glycolytic enzyme | Also has non-glycolytic roles; common loading control |
| ENO1 | Enolase 1; glycolytic enzyme | Multifunctional; studied in cancer and autoimmunity |
| LDHA | Lactate dehydrogenase A; converts pyruvate to lactate | Regulates anaerobic glycolysis; cancer target |
| PC | Pyruvate carboxylase; converts pyruvate to oxaloacetate | Anaplerotic role in TCA cycle; important in liver and development |
| MPC1 | Mitochondrial pyruvate carrier 1; imports pyruvate into mitochondria | Essential for mitochondrial glucose oxidation |
| TIGAR | TP53-induced glycolysis and apoptosis regulator; modulates glycolysis and PPP | Links p53 to glucose catabolism; cancer research |
| mTOR | Mechanistic target of rapamycin; senses glucose availability via DHAP | Central regulator of growth and catabolism |
How Is glucose catabolic process Regulated?
Glucose catabolic process is regulated at multiple levels. Acute regulation occurs through allosteric control of key enzymes such as phosphofructokinase and pyruvate kinase, which respond to ATP, AMP, and citrate levels. Hormonal regulation by insulin and glucagon controls glucose uptake and enzyme expression. Nutrient-sensing pathways, particularly mTORC1, are directly modulated by glycolytic intermediates like dihydroxyacetone phosphate, which signals glucose availability to promote anabolic growth. AMPK, activated by low energy status, inhibits anabolic processes and stimulates catabolism. In obesity, competitive catabolism between glucose and other fuels can lead to hyperglycemia and hyperinsulinemia, indicating systemic dysregulation. Metformin treatment paradoxically increases endogenous glucose production while affecting catabolic flux, highlighting complex feedback loops. In Ataxia-Telangiectasia, alpha-ketoglutarate supplementation improves insulin resistance and metabolic inflexibility, suggesting that TCA cycle intermediates can modulate systemic glucose catabolism. Transcriptional regulation by HIF-1, c-Myc, and p53 also shapes glycolytic capacity in cancer and normal tissues.
glucose catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HK2 | Cancer metabolism; glycolysis upregulation | Knockout in cancer cell lines; xenograft models |
| G6PD | Cancer; redox balance; hemolytic anemia | Point mutation knock-in in cell lines; metabolic profiling [1,6] |
| PDHX | Developmental failure; mitochondrial metabolism | Knockout mouse; midgestation lethality |
| SLC2A4 | Type 2 diabetes; insulin resistance | Knock-in of human variants; glucose uptake assays |
| IDH2 | Cancer; TCA cycle mutations | Knock-in of mutant IDH2; metabolomics |
Glucose Catabolism in Obesity and Type 2 Diabetes
Dysregulated glucose catabolism contributes to hyperglycemia and hyperinsulinemia in obesity. Competitive catabolism between glucose and other fuels, such as branched-chain amino acids and fatty acids, can exacerbate these conditions. Metformin, a first-line therapy for type 2 diabetes, modulates endogenous glucose production, although its effects on catabolic flux are complex and may paradoxically increase glucose production. Insulin resistance in Ataxia-Telangiectasia is associated with metabolic inflexibility, and alpha-ketoglutarate supplementation mitigates these defects in mouse models. These findings highlight glucose catabolic process as a therapeutic target in metabolic disease.
Glucose Catabolism in Cancer
Cancer cells often reprogram glucose catabolism to support rapid proliferation and survival. During epithelial-mesenchymal transition (EMT), catabolic metabolism is rewired, with increased glycolysis and altered mitochondrial function. The pentose phosphate pathway is upregulated to provide NADPH and ribose-5-phosphate for biosynthesis. Targeting glycolytic enzymes such as hexokinase 2 or lactate dehydrogenase A is an active area of cancer drug development. Understanding how oncogenes and tumor suppressors regulate glucose catabolism is essential for designing effective therapies.
Glucose Catabolism in Development
Compartmentalized metabolism, including glucose catabolism, is essential for midgestation mammalian development. Genetic studies in mice have shown that disrupting specific catabolic steps causes developmental failure, indicating that glucose breakdown provides critical energy and biosynthetic precursors for the embryo. The TCA cycle and oxidative phosphorylation are particularly important during organogenesis. These findings have implications for understanding birth defects and metabolic disorders in humans.
From glucose catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a glycolytic enzyme impair cell proliferation? | CRISPR knockout in cancer cell lines [1,6] |
| Does a specific point mutation in a TCA cycle enzyme alter flux? | CRISPR point mutation knock-in in cell lines |
| Can a tagged enzyme be used to track localization? | Knock-in of fluorescent tag (e.g., GFP) |
| Does overexpression of a transporter increase glucose uptake? | CRISPR overexpression (e.g., CRISPRa) or lentiviral overexpression |
| Which genes are essential for glucose catabolism in vivo? | CRISPR library screening in mouse models |
| Does a metabolic intermediate rescue a knockout phenotype? | Knockout plus metabolite supplementation |
How to Study the glucose catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 13C-glucose tracing | Flux through glycolysis, PPP, TCA cycle | Cancer metabolism, diabetes research [1,2] |
| RNA-seq | Gene expression changes | Identifying regulators of glucose catabolism [5,6] |
| CRISPR library screening | Essential genes for glucose-dependent growth | Functional genomics in cancer and metabolism |
| Proteomics | Enzyme abundance and modifications | Pathway regulation studies |
| Metabolomics | Steady-state metabolite levels | Biomarker discovery and pathway analysis |
| Live-cell imaging | Real-time ATP, NADH, or pH changes | Dynamic metabolic studies |
| Seahorse assay | Oxygen consumption and extracellular acidification | Mitochondrial function and glycolysis |
| Western blot | Protein expression and phosphorylation | Validation of key enzymes |
Metabolic Flux Analysis
Metabolic flux analysis using stable isotope tracers (e.g., 13C-glucose) measures the rate of glucose catabolism through glycolysis, the pentose phosphate pathway, and the TCA cycle. This method provides quantitative insights into pathway activity and is often combined with mass spectrometry. It is used to study cancer metabolism, diabetes, and developmental metabolism [1,2,5].
Genomic and Transcriptomic Profiling
RNA-seq and single-cell RNA-seq can identify expression changes in genes involved in glucose catabolism under different conditions. CRISPR library screening coupled with sequencing can uncover genes required for glucose-dependent growth. These approaches are powerful for discovering novel regulators and biomarkers [1,5,6].
Proteomics and Metabolomics
Proteomics quantifies enzyme abundance and post-translational modifications, while metabolomics measures steady-state levels of metabolites such as glucose-6-phosphate, pyruvate, and lactate. Together, they provide a comprehensive view of catabolic pathway activity and regulation [2,7].
Imaging and Reporter Assays
Fluorescent reporters for ATP, NADH, or pH can monitor glycolytic activity in live cells. Genetically encoded sensors for glucose or lactate enable real-time tracking of catabolic flux. These methods are useful for studying spatial and temporal dynamics of glucose catabolism [1,6].
How CRISPR Can Be Used to Study GO:0006007 glucose catabolic process
Knockout
CRISPR knockout is used to delete genes encoding enzymes or transporters in glucose catabolic process, such as HK2 or SLC2A1. This allows researchers to test whether a specific gene is required for glycolysis, cell proliferation, or survival under different glucose conditions. Knockout cell lines can be analyzed by metabolic flux assays and metabolomics to quantify pathway activity [1,6].
Point Mutation
CRISPR point mutation knock-in introduces specific amino acid changes to study enzyme kinetics, allosteric regulation, or disease-associated variants. For example, mutations in IDH2 or PDHX can be modeled to understand their impact on TCA cycle flux and cellular metabolism. This approach is valuable for dissecting structure-function relationships in glucose catabolism.
Knock-in
CRISPR knock-in can insert tags (e.g., GFP, HA) or reporter genes into endogenous loci to track protein localization and expression. It can also be used to introduce human disease alleles into model organisms or cell lines. For glucose catabolism, knock-in of fluorescent tags on glycolytic enzymes enables live-cell imaging of pathway dynamics.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression is used to increase expression of genes involved in glucose catabolism, such as GLUT1 or hexokinase. This helps determine whether increased catabolic capacity enhances growth or survival under metabolic stress. Overexpression models are also used to study oncogene-driven metabolic reprogramming [6,8].
How EDITGENE Supports glucose catabolic process Research
Researchers studying glucose catabolic process-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, disease progression, or therapeutic response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation of genes in glucose catabolism.
Contact EDITGENE today to design your custom CRISPR model for glucose catabolic process research.
Frequently Asked Questions About glucose catabolic process
What is glucose catabolic process GO:0006007?
GO:0006007 is a Gene Ontology biological process term defined as the chemical reactions and pathways resulting in the breakdown of glucose, the aldohexose gluco-hexose. It includes glycolysis, the pentose phosphate pathway, and mitochondrial oxidation [1,2].
What genes are involved in glucose catabolic process?
Key genes include HK2, G6PD, PKM, PDHX, IDH2, SDHA, SLC2A1, SLC2A4, GCK, PFKM, GAPDH, ENO1, LDHA, PC, MPC1, TIGAR, and mTOR [1,2,5,6].
How is glucose catabolic process regulated?
It is regulated by allosteric control of enzymes, hormonal signals like insulin and glucagon, and nutrient-sensing pathways such as mTORC1, which is signaled by dihydroxyacetone phosphate. AMPK and transcriptional regulators also play roles [5,7].
Why is glucose catabolism important in cancer?
Cancer cells often reprogram glucose catabolism to support rapid growth and survival, including during epithelial-mesenchymal transition (EMT). Targeting glycolytic enzymes is a therapeutic strategy.
What diseases are linked to glucose catabolic process?
Diseases include obesity, type 2 diabetes, cancer, and developmental disorders. Competitive catabolism drives hyperglycemia in obesity, and metabolic inflexibility is seen in Ataxia-Telangiectasia.
How can I study glucose catabolic process in the lab?
Common methods include 13C-glucose tracing, RNA-seq, CRISPR library screening, proteomics, metabolomics, and live-cell imaging [1,2,5,6].
What CRISPR models are available for glucose catabolism research?
EDITGENE offers knockout, point mutation knock-in, tagged knock-in, overexpression, and CRISPR library screening for genes in glucose catabolic process [1,2,5].
Does glucose catabolism occur in mitochondria?
Yes, the mitochondrial phase includes pyruvate oxidation, the TCA cycle, and oxidative phosphorylation. Compartmentalized metabolism is essential for development.
What is the role of mTORC1 in glucose catabolism?
mTORC1 senses glucose availability via dihydroxyacetone phosphate and promotes anabolic growth when glucose is abundant.
How does metformin affect glucose catabolism?
Metformin treatment can paradoxically increase endogenous glucose production while modulating catabolic flux, illustrating complex regulation.
Conclusion
Glucose catabolic process (GO:0006007) is a fundamental biological process that breaks down glucose to produce energy and biosynthetic precursors. Its dysregulation is central to metabolic diseases, cancer, and developmental disorders [2,5,6]. Understanding the genes, regulation, and disease links of this pathway requires robust experimental models. EDITGENE provides comprehensive CRISPR services to support functional studies of glucose catabolism, from single-gene knockouts to genome-wide screens. By leveraging these tools, researchers can accelerate discoveries in metabolism and identify new therapeutic targets.
References
- 1. Orozco JM et al.. 2020. Dihydroxyacetone phosphate signals glucose availability to mTORC1.. Nat Metab 2(9):893-901 PMID: 32719541
- 2. Solmonson A et al.. 2022. Compartmentalized metabolism supports midgestation mammalian development.. Nature 604(7905):349-353 PMID: 35388219
- 4. Methnani J et al.. 2025. Pharmacophysiological insights into the paradoxical increase in endogenous glucose production with metformin treatment.. Biochem Pharmacol 240:117112 PMID: 40619021
- 5. Weilandt DR et al.. 2026. Competitive catabolism drives hyperglycemia and hyperinsulinemia in obesity.. Cell Metab 38(9):1786-1801.e9 PMID: 42480542
- 6. Cha YH et al.. 2015. Catabolic metabolism during cancer EMT.. Arch Pharm Res 38(3):313-20 PMID: 25634102
- 7. Sun JK et al.. 2025. Alpha-ketoglutarate mitigates insulin resistance and metabolic inflexibility in a mouse model of Ataxia-Telangiectasia.. Nat Commun 16(1):9312 PMID: 41120320
- 8. Bisson LF et al.. 1993. Yeast sugar transporters.. Crit Rev Biochem Mol Biol 28(4):259-308 PMID: 8403984
